XNK Therapeutics AB

ABBankrupt

Org 5568946601Research and experimental development on natural sciences and engineering· NACE 7210Est. 2012 · 14 years old0 employees

Overview Financials People & ownership Related companies

XNK Therapeutics AB is a Swedish AB, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2012, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2022

SEK 0

EBITDA margin

—

Net profit 2022

SEK -74,6M

-116% vs 2021

Key ratios

See full ratios →

86.7%

This company

20182022

6.5×

This company

20182022

-79.3%

This company

20182022

EBITDA — year on year

SEK millions

Frequently asked questions

What is the Org number of XNK Therapeutics AB?

XNK Therapeutics AB is registered with Bolagsverket / SCB under Org 5568946601.

Who is the CEO of XNK Therapeutics AB?

Johan Axel Living is the CEO of XNK Therapeutics AB, in role since 2020.

Who is the chairman of XNK Therapeutics AB?

Nils Gunnar Mattsson chairs the board of XNK Therapeutics AB, in role since 2022.

Revenue	SEK 0	—
EBITDA	SEK -74,2M	-118%
Net profit	SEK -74,6M	-116%
Total assets	SEK 94,1M	+122%
Equity	SEK 81,6M	+178%
Employees	0	—

XNK Therapeutics AB

Key ratios

EBITDA — year on year

Company information

Frequently asked questions

More on XNK Therapeutics AB

Key ratios

EBITDA — year on year

Company information

Frequently asked questions

More on XNK Therapeutics AB

Key figures

Contact